$245 M to Support US Naval Research Laboratory
- Contract will allow IOMAXIS to provide research, development and technical support to initiatives at the Naval Research Lab
IOMAXIS , a leader in innovative technologies and mission-focused solutions for the intelligence, defense and civilian government markets, announced today that it has been awarded a seat on an indefinite-delivery, indefinite-quantity contract valued at up to $245 million to give technological support and assistance to the U.S. Naval Research Laboratory . Through opportunities under this contract, IOMAXIS will provide research, development and technical support to strengthen the NRL’s initiatives in defense, intelligence and security technologies.
“We are honored to have this opportunity to work with the Naval Research Laboratory,” said Dennis Kelly , CEO of IOMAXIS. “Working with the lab allows IOMAXIS to contribute to the creation of disruptive, innovative technologies that are core requirements today for the defense of our nation. As a veteran-owned business, we’re extremely proud to have this opportunity to continue to give back to our armed forces in a manner that helps solve some of their most difficult challenges.”
Global Military UAV Market Forecast to 2022
NRL, the corporate research lab for the Navy and Marine Corps, conducts a broad program of scientific research, technology and advanced development. IOMAXIS will support the NRL in communications, computing and data storage, operational IT, and security initiatives. The IDIQ contract, which has a fixed five-year ordering period, serves the NRL’s Washington, D.C.-area branch and has the potential to support global initiatives.
IOMAXIS and its subject matter experts have a deep understanding and a positive record of performance supporting the U.S. military through many organizations within the Department of Defense. The company has worked frequently with the Navy on various programs and has provided similar technology and services to support the Air Force Research Laboratory.
Source : IOMAXIS - view original press release
Feb 28 - Mar 2, 2017 - London, United Kingdom